Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.

Autor: Nester C; Department of Pediatrics, Division of Nephrology, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Decker DA; Apellis Pharmaceuticals Inc., Waltham, Massachusetts., Meier M; Novartis Inc., Basel, Switzerland., Aslam S; BioCryst Pharmaceuticals Inc., Durham, North Carolina., Bomback AS; Columbia University Irving Medical Center, New York, New York., Caravaca-Fontán F; Research Institute 'Hospital 12 de Octubre,' Madrid, Spain., Cook TH; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Feldman DL; National Kidney Foundation, New York, New York., Fremeaux-Bacchi V; Hôpital Europeén Georges Pompidou, Paris, France., Gale DP; Department of Renal Medicine, University College of London, London, United Kingdom.; Rare Kidney Disease Registry (RaDaR), Bristol, United Kingdom., Gooch A; BioCryst Pharmaceuticals Inc., Durham, North Carolina., Johnson S; Great North Children's Hospital, Newcastle upon Tyne, United Kingdom., Licht C; The Hospital for Sick Children, Toronto, Ontario, Canada., Mathur M; Visterra Inc., Waltham, Massachusetts., Pickering MC; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Praga M; Department of Medicine, Nephrology Department, Complutense University, Madrid, Spain., Remuzzi G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Selvarajah V; Research and Early Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Smith RJ; Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Tabriziani H; Natera Inc., Austin, Texas., van de Kar N; Radboud Institute for Molecular Life Sciences, Amalia Children's Hospital, Radboud University, Nijmegen, The Netherlands., Wang Y; Novartis Inc., East Hanover, New Jersey., Wong E; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom., Mistry K; Center for the Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Lim M; Kidney Health Initiative, American Society of Nephrology, Washington, DC., Portillo C; Kidney Health Initiative, American Society of Nephrology, Washington, DC., Balogun S; Kidney Health Initiative, American Society of Nephrology, Washington, DC., Trachtman H; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan., Thompson A; Center for the Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

Publikováno v: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2024 Jun 03. Date of Electronic Publication: 2024 Jun 03.

Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.

Autor: Decker, DA¹, Grant, C², Oh, L¹, Becker, PM¹, Young, D¹, Jordan, S³

Publikováno v: Lupus. Jul2014, Vol. 23 Issue 8, p802-812. 11p.

Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept.

Autor: Decker DA; Former employee of Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA., Higgins P; Former employee of Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA., Hayes K; Mallinckrodt Pharmaceuticals, 675 McDonnell Blvd, Bedminster, NJ, 63042, USA., Bollinger C; Mallinckrodt Pharmaceuticals, 675 McDonnell Blvd, Bedminster, NJ, 63042, USA., Becker P; Former employee of Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA., Wright D; Mallinckrodt Pharmaceuticals, 675 McDonnell Blvd, Bedminster, NJ, 63042, USA. dale.wright@mnk.com.

Publikováno v: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2020 Aug 31; Vol. 21 (1), pp. 586. Date of Electronic Publication: 2020 Aug 31.

Spatial analysis of the land degradation in Capão do Leão municipality, RS - Brazil

Autor: Cruz, Ricardo Decker da

Publikováno v: Repositório Institucional da UFPEL
Universidade Federal de Pelotas (UFPEL)
instacron:UFPEL

Made available in DSpace on 2014-08-20T13:25:36Z (GMT). No. of bitstreams: 1 Tese_Ricardo_ Decker_ Cruz.pdf: 12162112 bytes, checksum: 0975a21caf72286cb9cd4c037c2fb34e (MD5) Previous issue date: 2011-09-08 The nowadays model of development has as a b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::a6a75dc8a3d15001ccc5d7e8042ada4b
http://repositorio.ufpel.edu.br/handle/ri/1132

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.